Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China · Delayed Price · Currency is CNY 67.10
-1.22 (-1.79%)
Sep 29, 2025, 2:45 PM CST
SHE:300832 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 1,696 | 1,828 | 1,654 | 1,328 | 973.7 | 939.15 | Upgrade |
Depreciation & Amortization | 190.52 | 182.09 | 154.33 | 116.48 | 97 | 79.15 | Upgrade |
Other Amortization | 40.25 | 36.97 | 24.87 | 15.68 | 13.4 | 11.79 | Upgrade |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0.05 | -0.62 | -0.1 | 0.25 | Upgrade |
Asset Writedown & Restructuring Costs | 1.23 | 0.43 | 1.52 | 1.52 | 1.86 | 0.63 | Upgrade |
Loss (Gain) From Sale of Investments | -100.67 | -118.47 | -92.94 | -76.95 | -71.67 | -58.71 | Upgrade |
Provision & Write-off of Bad Debts | 27.12 | 28.01 | 10.78 | 14.32 | -7.37 | 11.53 | Upgrade |
Other Operating Activities | 85.74 | 89.84 | -9.03 | -50.41 | 26.55 | 29.89 | Upgrade |
Change in Accounts Receivable | -483.57 | -612.94 | -277.18 | -240.16 | -154.66 | -60.45 | Upgrade |
Change in Inventory | -209.58 | -382.5 | -136.49 | -229.95 | -227.73 | -222.51 | Upgrade |
Change in Accounts Payable | -52.26 | 304.21 | 84.02 | 162.12 | 10.03 | 119.02 | Upgrade |
Change in Other Net Operating Assets | - | - | - | -80.71 | 93.88 | 141.4 | Upgrade |
Operating Cash Flow | 1,199 | 1,356 | 1,418 | 962.39 | 773.22 | 976.65 | Upgrade |
Operating Cash Flow Growth | -20.58% | -4.36% | 47.37% | 24.47% | -20.83% | 17.42% | Upgrade |
Capital Expenditures | -384.9 | -439.2 | -322.2 | -403.22 | -342.94 | -254.82 | Upgrade |
Sale of Property, Plant & Equipment | 0.11 | 0.11 | 0.09 | 0.66 | 0.24 | 1.78 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | -16.62 | - | - | Upgrade |
Investment in Securities | 400.97 | -361.86 | -53.47 | -261.5 | -634.54 | -2,299 | Upgrade |
Other Investing Activities | 57.29 | 95.8 | 84.85 | 86.96 | 52.67 | 57.74 | Upgrade |
Investing Cash Flow | 73.47 | -705.15 | -290.73 | -593.72 | -924.57 | -2,494 | Upgrade |
Long-Term Debt Repaid | - | -4.24 | -4.11 | -4.05 | -3.59 | - | Upgrade |
Net Debt Issued (Repaid) | -4.19 | -4.24 | -4.11 | -4.05 | -3.59 | - | Upgrade |
Issuance of Common Stock | - | - | - | - | 129.56 | 1,284 | Upgrade |
Repurchase of Common Stock | - | - | -16.29 | -21.62 | - | - | Upgrade |
Common Dividends Paid | -1,021 | -785.96 | -548.21 | -471.78 | -413.4 | -618.98 | Upgrade |
Other Financing Activities | - | - | - | - | 0 | -11.79 | Upgrade |
Financing Cash Flow | -1,026 | -790.2 | -568.61 | -497.45 | -287.43 | 653.67 | Upgrade |
Foreign Exchange Rate Adjustments | 24.31 | 12.67 | 8.69 | -9.13 | -14 | -33.49 | Upgrade |
Net Cash Flow | 271.67 | -126.25 | 567.66 | -137.9 | -452.78 | -897.61 | Upgrade |
Free Cash Flow | 814.54 | 917.24 | 1,096 | 559.17 | 430.28 | 721.84 | Upgrade |
Free Cash Flow Growth | -29.83% | -16.32% | 96.02% | 29.96% | -40.39% | 43.05% | Upgrade |
Free Cash Flow Margin | 18.06% | 20.22% | 27.89% | 18.35% | 16.90% | 32.89% | Upgrade |
Free Cash Flow Per Share | 1.04 | 1.17 | 1.40 | 0.71 | 0.55 | 0.96 | Upgrade |
Cash Income Tax Paid | 340.51 | 296.84 | 192.82 | 80.06 | 200.54 | 181.52 | Upgrade |
Levered Free Cash Flow | 375.28 | 551.87 | 705.91 | 198.4 | 213.19 | 555.67 | Upgrade |
Unlevered Free Cash Flow | 375.57 | 552.14 | 706.18 | 198.57 | 213.29 | 555.67 | Upgrade |
Change in Working Capital | -741.1 | -690.86 | -324.83 | -385.54 | -260.16 | -37.02 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.